NNN & IHS HP/DP Webinar – Southwest Tribal Tobacco Coalition
The Inter-Tribal Council of Michigan’s National Native Network with Indian Health Service Health Promotion & Disease Prevention and the Indian Health Services Clinical Support Center (Accredited Provider) present a webinar series: Cancer Risk Reduction in Indian Country.
Title: Southwest Tribal Tobacco Coalition
Date: Wednesday, August 29, 2018
Time: 3 – 4 PM EDT
Presenter:
Janna Vallo, MPA, CPS
Commercial Tobacco Control and Prevention Coordinator
Albuquerque Area Southwest Tribal Epidemiology Center
Learning Outcomes/Objectives:
By the end of the webinar, participants will be able to:
- Differentiate between traditional and commercial tobacco and its use.
- Build a community tobacco control coalition that provides cessation support for American Indian adults and youth who smoke cigarettes, and those who use other types of commercial tobacco.
- Implement practices that incorporate meaningful participation from coalition members.
VIEW HERE:
Target Audience: Nurses, health educators, administrators, and support staff working with American Indian and/or Alaska Native communities.
After registering, you will receive a confirmation email containing information about joining the webinar.
Funding for this webinar was made possible by the Centers for Disease Control and Prevention DP13-1314 Consortium of National Networks to Impact Populations Experiencing Tobacco-Related and Cancer Health Disparities. Webinar contents do not necessarily represent the official views of the Centers for Disease Control and Prevention.
Faculty Disclosure Statement: As a provider accredited by ACCME, ANCC, and ACPE, the IHS Clinical Support Center must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Course directors/coordinators, planning committee members, faculty, reviewers and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. All those who are in a position to control the content of this educational activity have completed the disclosure process and have indicated that they do not have any significant financial relationships or affiliations with any manufacturers or commercial products to disclose.
No commercial interest support was used to fund this activity.
Space is limited.
After registering, you will receive a confirmation email containing information about joining the webinar.